Sign in

Private company

Veradigm Inc.

Veradigm Inc. is an American computer integrated systems design services company.1 It is headquartered in Chicago, Illinois.1

Last updated Oct 21, 2026.

Overview

  • IndustryServices-Computer Integrated Systems Design1
  • HeadquartersChicago, Illinois1
  • Incorporated inDE2
  • Business address222 Merchandise Mart Plaza, Suite 2024, Chicago, Il 606542
  • Filer categoryAccelerated filer2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

50.8%Gross margin4
-32.7%Operating margin4
-49.0%Net margin4
-5.0%Revenue growth, 20244
-36.3%Return on equity4
0.09×Debt to equity4
-$21.6MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue39¢$292.2M
  • Research and development14¢$108.3M
  • Selling, general and admin36¢$269.4M
  • Interest2¢$15.0M
  • Income tax9¢$69.5M

Out of $594.4M in revenue.4 The company lost money this year.

Financial statements

Revenue564$594.4M in 2024−64% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $1.6B$1.6B20192020: $556.1M$556.1M2020−66%2021: $577.4M$577.4M2021+4%2022: $588.0M$588.0M2022+2%2023: $626.0M$626.0M2023+6%2024: $594.4M$594.4M2024−5%
Gross profit564$302.2M in 2024−50% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $610.3M$610.3M20192020: $264.2M$264.2M2020−57%2021: $282.4M$282.4M2021+7%2022: $308.4M$308.4M2022+9%2023: $341.5M$341.5M2023+11%2024: $302.2M$302.2M2024−11%
Operating income564-$194.7M in 2024+95% since 2019
-$200.0M-$100.0M0$100.0M2019: -$99.7M-$99.7M20192020: $7.9M$7.9M20202021: $76.8M$76.8M2021+867%2022: -$27.1M-$27.1M20222023: $34.7M$34.7M20232024: -$194.7M-$194.7M2024
Net income564-$291.5M in 2024+60% since 2019
-$500.0M-$250.0M0$250.0M$500.0M$750.0M2019: -$182.6M-$182.6M20192020: $696.1M$696.1M20202021: $139.6M$139.6M2021−80%2022: -$86.5M-$86.5M20222023: $49.2M$49.2M20232024: -$291.5M-$291.5M2024
Fiscal year201920202021202220232024
Revenue$1.6B5$556.1M6$577.4M6$588.0M4$626.0M4$594.4M4
Cost of revenue$1.0B5$291.9M6$295.0M6$279.6M4$284.5M4$292.2M4
Gross profit$610.3M5$264.2M6$282.4M6$308.4M4$341.5M4$302.2M4
Research and development$245.4M5$78.6M6$84.1M6$97.9M4$97.0M4$108.3M4
Selling, general and admin$400.8M5$155.7M6$111.8M6$169.2M4$200.9M4$269.4M4
Operating income-$99.7M5$7.9M6$76.8M6-$27.1M4$34.7M4-$194.7M4
Interest$43.2M5$34.3M6$12.9M6$6.4M4$5.3M4$15.0M4
Income before tax$157.7M6-$62.7M4$60.2M4-$214.9M4
Income tax-$43.3M5$15.1M6$29.9M6-$43.8M4$10.7M4$69.5M4
Net income-$182.6M5$696.1M6$139.6M6-$86.5M4$49.2M4-$291.5M4
Earnings per share-$1.105$4.376$1.076-$0.774$0.464-$2.704
Earnings per share (diluted)-$1.105$4.376$1.016-$0.774$0.414-$2.704
Shares (weighted, basic)130.1M shares6112.1M shares4107.4M shares4108.2M shares4
Shares (weighted, diluted)138.7M shares6112.1M shares4124.6M shares4108.2M shares4

Compare Veradigm Inc. with another company

Corporate structure

Veradigm Inc. sits at the top of its group. 27 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Veradigm Inc.

  • Veradigm Inc. Chicago, Illinois
    • 2bPrecise, LLC Subsidiary · Delaware, United States
    • Allscripts Analytics, LLC Subsidiary · Delaware, United States
    • Allscripts Healthcare IT (Canada) Corporation (f/k/a NantHealth Canada, Inc.) Subsidiary · Canada
    • Allscripts Healthcare US, LP Subsidiary · Delaware, United States
    • Allscripts Holdings 2, LLC Subsidiary · Delaware, United States
    • Allscripts Holdings, LLC Subsidiary · Delaware, United States
    • Allscripts IHC, LLC Subsidiary · Delaware, United States
    • Allscripts Next, LLC Subsidiary · Delaware, United States
    • Allscripts Software, LLC Subsidiary · Delaware, United States
    • Babel Health, LLC Subsidiary · Delaware, United States
    • California Healthcare Medical Billing, LLC Subsidiary · California, United States
    • Cascade Bio, Inc. Subsidiary · Delaware, United States
    • Coniston Exchange, LLC Subsidiary · Delaware, United States
    • Evalytica, LLC Subsidiary · California, United States
    • Health Grid Holding Company LLC Subsidiary · Delaware, United States
    • Health Grid, LLC Subsidiary · Florida, United States
    • HealthGrid Coordinated Care Solutions LLC. Subsidiary · Delaware, United States
    • Mahathi Software LLC. Subsidiary · Florida, United States
    • Mercury Investments, LLC Subsidiary · Delaware, United States
    • Mercury IT International Limited Subsidiary · Bangladesh
    • PF2 EIS LLC Subsidiary · Delaware, United States
    • Practice Fusion, Inc. Subsidiary · Delaware, United States
    • Pulse8, LLC Subsidiary · Maryland, United States
    • Ringadoc, Inc. Subsidiary · Delaware, United States
    • Veradigm Coding Services, LLC Subsidiary · New Hampshire, United States
    • and 1 more

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Veradigm Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Computer equipment and software$190.7M4 Dec 31, 2024$162.2M4 Dec 31, 2023+17.6%
Property and equipment, before depreciation$168.0M4 Dec 31, 2024$165.7M4 Dec 31, 2023+1.3%
Accumulated depreciation$162.8M4 Dec 31, 2024$160.3M4 Dec 31, 2023+1.5%
Property and equipment, net$5.2M4 Dec 31, 2024$5.4M4 Dec 31, 2023−4.6%
Operating-lease assets (leased space)$10.2M4 Dec 31, 2024$9.1M4 Dec 31, 2023+11.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$294.3M4 Dec 31, 2024$446.6M4 Dec 31, 2023−34.1%
Debt securities available for sale$102.4M4 Dec 31, 2024$128.7M4 Dec 31, 2023−20.5%
Stakes in other companies (equity method)$36.1M4 Dec 31, 2024$29.5M4 Dec 31, 2023+22.6%
Long-term investments$98.7M4 Dec 31, 2024$98.5M4 Dec 31, 2023+0.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$520.7M4 Dec 31, 2024$532.5M4 Dec 31, 2023−2.2%
Intangible assets, net (excluding goodwill)$80.8M4 Dec 31, 2024$75.1M4 Dec 31, 2023+7.7%
Finite-lived intangibles, gross$469.1M4 Dec 31, 2024$448.3M4 Dec 31, 2023+4.6%
Accumulated amortization$388.3M4 Dec 31, 2024$373.2M4 Dec 31, 2023+4.0%
Finite-lived intangibles, net$80.8M4 Dec 31, 2024$75.1M4 Dec 31, 2023+7.7%

Properties, in its own words

Veradigm leases properties used in its principal operations in the United States and India, with approximately 83,000 square feet in the United States and 44,000 square feet in India. Our corporate headquarters is located in Chicago, Illinois where we lease approximately 40,000 square feet of office space. We also have a significant presence in Raleigh, North Carolina, where we operate in 56,000 square feet of office space available to us pursuant to a joint use agreement we executed with Altera at the time of our divestiture of the HLPP business.

Our leased facilities house various sales, services, support, development, and data processing functions, as well as certain ancillary functions and other back-office functions related to our operations. The properties serve all of our business segments, including Provider, Payer and Life Science. Our existing facilities are adequate to meet our current business requirements.

Item 2 of the 10-K filed May 26, 2026.8

Leadership

Who has led Veradigm Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Glen Tullman2006–2012
  2. Richard J. Poulton2022–2023
  3. Thomas Langan2024–2025
  4. Donald Trigg2025–now

Chair

  1. Michael Lawrie2008
  2. Philip M. Pead2011
  3. Greg Garrison2024

President

  1. John G. Cull2006–2009
  2. Laurie McGraw2006–2011
  3. Lee Shapiro2006–2012
  4. Mark Thierer2006
  5. David A. Bond2006–2008
  6. Thomas S. Leisher2007–2008
  7. Jeff Surges2010
  8. Richard J. Poulton2015–2022
  9. Thomas Langan2022–2024

Chief financial officer

  1. William J. Davis2006–2012
  2. W. David Morgan2012
  3. Richard J. Poulton2012–2022
  4. Melinda D. Whittington2016–2017
  5. Dennis Olis2017–2020
  6. Leah Jones2022–2023
  7. Leland Westerfield2024
  8. Christian Greyenbuhl2026–now

Chief operating officer

  1. Joseph E. Carey2006–2007
  2. Benjamin Bulkley2007–2008
  3. Lee Shapiro2008–2011
  4. Eileen McPartland2009–2011
2010201520202025
Board members and other officers (68)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • 2bPrecise, LLC Delaware3
  • Allscripts Analytics, LLC Delaware3
  • Allscripts Healthcare IT (Canada) Corporation (f/k/a NantHealth Canada, Inc.) Canada3
  • Allscripts Healthcare US, LP Delaware3
  • Allscripts Holdings 2, LLC Delaware3
  • Allscripts Holdings, LLC Delaware3
  • Allscripts IHC, LLC Delaware3
  • Allscripts Next, LLC Delaware3
  • Allscripts Software, LLC Delaware3
  • Babel Health, LLC Delaware3
  • California Healthcare Medical Billing, LLC California3
  • Cascade Bio, Inc. Delaware3
  • Coniston Exchange, LLC Delaware3
  • Evalytica, LLC California3
  • Health Grid Holding Company LLC Delaware3
  • Health Grid, LLC Florida3
  • HealthGrid Coordinated Care Solutions LLC. Delaware3
  • Mahathi Software LLC. Florida3
  • Mercury IT International Limited Bangladesh3
  • Mercury Investments, LLC Delaware3
  • PF2 EIS LLC Delaware3
  • Practice Fusion, Inc. Delaware3
  • Pulse8, LLC Maryland3
  • Ringadoc, Inc. Delaware3
All 27 listed subsidiaries
  • Veradigm Coding Services, LLC New Hampshire3
  • Veradigm India Private Limited India3
  • Veradigm LLC North Carolina3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.Aug 25, 2010 to Dec 12, 20222
  • ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC.Jul 11, 2008 to Aug 24, 20102
  • ALLSCRIPTS HEALTHCARE SOLUTIONS INCFeb 14, 2001 to Oct 10, 20082
  • ALLSCRIPTS HOLDING INCNov 8, 2000 to Jan 12, 20012

Timeline

  1. Sep 15, 20268-K Regulation FD disclosure100
  2. Sep 8, 20268-K Regulation FD disclosure101
  3. Sep 8, 20268-K Other events102
  4. Aug 17, 20268-K Regulation FD disclosure103
  5. Jun 26, 20268-K Other events104
  6. May 26, 20268-K Results of operations105
  7. May 26, 20268-K Executive or director change106
  8. Apr 6, 20268-K Executive or director change; Regulation FD disclosure107
  9. Feb 24, 20268-K Other events108
  10. Feb 17, 20268-K Results of operations109
  11. Feb 2, 20268-K Entered a material agreement; Change to shareholders' rights; Regulation FD disclosure110
  12. Jan 20, 20268-K Entered a material agreement111
  13. Sep 2, 2025New chief executive Donald Trigg becomes CEO9
  14. Jun 20, 2024New chief executive Thomas Langan becomes CEO10
  15. May 11, 2022New chief executive Richard J. Poulton becomes CEO11
  16. Apr 26, 2006New chief executive Glen Tullman becomes CEO12

Calendar

When it reported results

  1. May 26, 2026Reported quarterly or annual results105
  2. Feb 17, 2026Reported quarterly or annual results109
  3. Sep 30, 2025Reported quarterly or annual results112
  4. Jun 23, 2025Reported quarterly or annual results113
  5. Mar 18, 2025Reported quarterly or annual results114
  6. Mar 13, 2024Reported quarterly or annual results115
  7. Feb 27, 2024Reported quarterly or annual results116
  8. Jan 10, 2024Reported quarterly or annual results117

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

288 filings to the SEC since October 2021: 4 annual reports, 4 quarterly reports, 78 major events, 138 insider forms, 40 large holders, 24 other. The latest 20:

  1. Sep 15, 20268-K EDGAR
  2. Sep 8, 20268-K EDGAR
  3. Sep 8, 20268-K EDGAR
  4. Aug 17, 20268-K EDGAR
  5. Aug 11, 2026NT 10-Q EDGAR
  6. Jun 26, 20268-K EDGAR
  7. Jun 3, 20264 EDGAR
  8. Jun 3, 20264 EDGAR
  9. Jun 3, 20264 EDGAR
  10. Jun 3, 20264 EDGAR
  11. Jun 3, 20264 EDGAR
  12. Jun 3, 20264 EDGAR
  13. Jun 3, 20264 EDGAR
  14. Jun 3, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Jun 3, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  16. May 27, 20263 EDGAR
  17. May 26, 20268-K/A EDGAR
  18. May 26, 202610-K EDGAR
  19. May 26, 20268-K EDGAR
  20. May 15, 2026SCHEDULE 13G/A EDGAR

The 288 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

35 open-market trades by officers, directors and large owners since October 2021: 6 buys and 29 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 1, 2024Sacks Jonathan SDirectorBuy3,997,875$6.00$24.0MForm 4
Mar 1, 2024SISITSKY PETERDirectorBuy3,997,875$6.00$24.0MForm 4
Feb 29, 2024Sacks Jonathan SDirectorBuy525,000$6.09$3.2MForm 4
Feb 29, 2024SISITSKY PETERDirectorBuy525,000$6.09$3.2MForm 4
Feb 28, 2024Sacks Jonathan SDirectorBuy5,700,000$6.81$38.8MForm 4
Feb 28, 2024SISITSKY PETERDirectorBuy5,700,000$6.81$38.8MForm 4
Feb 16, 2023Poulton Richard J.CEOSale10,000$17.33$173.3KForm 4
Feb 15, 2023Poulton Richard J.CEOSale10,000$17.38$173.8KForm 4
Dec 12, 2022Vakharia TejalSVP General CounselSale8,642$18.42$159.2KForm 4
Dec 6, 2022Stevens David BDirectorSale43,134$18.47$796.7KForm 4
Nov 16, 2022Poulton Richard J.CEOSale10,000$18.06$180.6KForm 4
Nov 15, 2022Poulton Richard J.CEOSale10,000$18.14$181.4KForm 4
Nov 10, 2022Vakharia TejalSVP General CounselSale19,793$18.15$359.2KForm 4
Sep 13, 2022Jones LeahChief Financial OfficerSale7,000$16.62$116.3KForm 4
Aug 17, 2022Jones LeahChief Financial OfficerSale3,921$17.65$69.2KForm 4
Aug 16, 2022Poulton Richard J.CEOSale10,000$17.44$174.4KForm 4
Aug 15, 2022Jones LeahChief Financial OfficerSale24$17.65$424Form 4
Aug 15, 2022Poulton Richard J.CEOSale10,000$17.46$174.6KForm 4
Jun 10, 2022Black PaulDirectorSale60,000$16.58$994.8KForm 4
Jun 7, 2022Black PaulDirectorSale75,000$17.35$1.3MForm 4

All 35 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Veradigm Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARVeradigm Inc.1
  • CIK0001124804
  • Employer ID (EIN)36-43927548
  • Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company8
  • Incorporated inDelaware8
  • Fiscal year endsDecember 311
  • Industry code (SIC)7373 Services-Computer Integrated Systems Design1
  • SEC reviewing officeOffice of Technology, Division of Corporation Finance1
  • Business address222 Merchandise Mart Plaza, Suite 2024, Chicago, IL 606541
  • Phone31250612001
  • Shares outstanding108,990,678 shares as of May 12, 20268
  • Public float$407.5M as of Jun 30, 20258
  • AuditorBDO USA, P.C., Raleigh, North Carolina PCAOB ID 243; it also attests to the company’s internal control over financial reporting8
  • On EDGAR sinceNov 8, 20001
  • Filings1,912 in all: 4 (867), 8-K (354), SC 13G/A (109), 3 (81), 10-Q (66), 4/A (49), SC 13G (43), DEFA14A (38)1
    All 56 form types

    425 (35), UPLOAD (29), 10-K (23), SC 13D/A (23), DEF 14A (21), 8-K/A (19), CORRESP (19), S-8 (16), NT 10-Q (12), 5 (9), ARS (9), SCHEDULE 13G/A (8), 10-K/A (6), 424B5 (6), SC 13D (6), 8-A12G/A (5), NT 10-K (5), SCHEDULE 13G (5), SC TO-I/A (4), 3/A (3), CT ORDER (3), 10-Q/A (2), 424B3 (2), 424B7 (2), 8-A12G (2), FWP (2), POS AM (2), PRER14A (2), S-3 (2), S-3/A (2), S-3ASR (2), S-4 (2), S-4/A (2), 10-KT (1), 25-NSE (1), 424B2 (1), 8-A12B (1), DEFM14A (1), DEFR14A (1), DFAN14A (1), EFFECT (1), PRE 14A (1), PREM14A (1), PX14A6G (1), S-8 POS (1), SC TO-I (1), SCHEDULE 13D (1), SCHEDULE 13D/A (1)

  • Latest filingsAnnual report (10-K) May 26, 2026
    Quarterly report (10-Q) Nov 7, 2022
    Proxy statement (DEF 14A) May 6, 2022
    Latest 8-K (8-K) Sep 15, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.01 per shareMDRX

From the cover page of the 10-K filed May 26, 2026 (Section 12(b) of the Exchange Act).8

Risk factors and legal proceedings

The risks Veradigm Inc. names in Item 1A of its 10-K filed May 26, 2026: 30 risks under these headings, as written.8

  • Risks Related to the Remediation Plan and Related Matters
  • Matters relating to and arising out of the implementation of the Remediation Plan have been time consuming and expensive, and may result in additional expense.
  • We are currently, and may in the future be, subject to stockholder litigation and other litigation regarding our disclosures relating to the periods reported in the 2022 Form 10-K (the “Affected Periods”). As a result, we have incurred significant legal expenses, and in the future, we could be subject to damages or other remedies that could result in material harm to our business, financial condition and operating results.
  • The delisting of our Common Stock may continue to have an adverse effect on the trading and price of our Common Stock, and our Common Stock might not be relisted, or once relisted, it might not remain listed.
  • The restatement and associated delay in filing SEC periodic reports have required us to obtain new financing arrangements, restricted our ability to access the capital markets and eliminated our eligibility to use Form S-8 registration statements for Company equity awards, which has adversely affected, and may continue to adversely affect, employee hiring and retention.
  • Risks Related to Our Industry
  • Markets for our products and services are highly competitive and subject to rapid technological change, and we may be unable to compete effectively.
  • Consolidation in the healthcare industry could materially and adversely impact our business, financial condition and operating results.
  • We operate in a highly regulated industry, with laws and regulations subject to change. Compliance with laws and regulations requires us to expend significant costs, and our failure to comply with existing or future laws and regulations could have an adverse effect on our future profitability and materially and adversely impact our business, financial condition and operating results.
  • Changes in interoperability, information blocking and other regulatory standards applicable to our software could require us to incur substantial additional development costs.
  • Regulatory changes impacting our customers could force us to reduce our prices.
  • Risks Related to Our Company
The other 21 risks
  • If we do not successfully evolve and execute against our business strategies, we may not be able to drive business growth.
  • We could fail to maintain and expand our business with our existing customers or effectively transition our customers to newer products.
  • Our products or services could fail to perform properly due to errors or similar problems, which could materially and adversely affect our business, financial condition and operating results.
  • Significant disruptions of information technology systems or breaches of information security could materially and adversely affect our business, financial condition and operating results.
  • We are facing additional investigations and proceedings from other governmental entities and third parties related to the same or similar conduct underlying the now expired settlement agreements that Practice Fusion entered into with the U.S. Department of Justice (the “DOJ”).
  • We have completed certain asset or business dispositions and have also acquired and invested in new businesses and technologies, each of which is subject to significant risks.
  • AI technology is new and developing, and may present business, compliance and reputational challenges that could lead to operational or reputational damage, competitive harm, legal and regulatory risk, and additional costs.
  • Our future success depends upon our ability to grow, and if we are unable to manage our growth effectively, we may incur unexpected expenses and be unable to meet our customers’ requirements.
  • Our business depends in part on our ability to establish and maintain additional strategic relationships.
  • We may be unable to protect, and we may incur significant costs in enforcing, our intellectual property rights.
  • We could be impacted by unfavorable results of legal proceedings and claims, such as being found to have infringed on a third party’s intellectual property rights.
  • Our success depends on our senior leadership team and our ability to hire and retain other key personnel, and any failure to attract and retain these critical human capital resources could materially adversely affect our business, financial condition and operating results.
  • Our independent content and service providers may fail to perform adequately or comply with laws, regulations or contractual covenants.
  • We may be liable for use of content we provide.
  • Our failure to license and integrate third-party technologies could harm our business.
  • Any potential additional cost reduction and restructuring activities could have long-term adverse effects on our business, financial condition and operating results.
  • Risks Related to Our Common Stock and Indebtedness
  • Our stockholder rights plan and anti-takeover provisions in our organizational documents and debt agreements may discourage or prevent a change of control, even if an acquisition would be beneficial to stockholders.
  • Our Common Stock price has experienced volatility and continues to be impacted by our delisting from Nasdaq.
  • Our current indebtedness, an event of default with respect thereto, our inability to obtain new financing or the terms with respect thereto could materially adversely affect our business, financial condition and operating results.
  • General Risk Factors
  • We could be subject to changes in our tax rates, the adoption of new United States or international tax legislation or exposure to additional tax liabilities.
  • We could incur additional asset impairment charges.

Legal proceedings

For information on legal proceedings, please refer to Note 21, “Commitments and Contingencies,” to our consolidated financial statements included in Part II, Item 8, “Financial Statements and Supplementary Data” of this Form 10-K.

The opening of Item 3, Legal Proceedings.8

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
    SEC EDGAROther events
  103. 103
  104. 104
    SEC EDGAROther events
  105. 105
  106. 106
  107. 107
  108. 108
    SEC EDGAROther events
  109. 109
  110. 110
  111. 111
  112. 112
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117
  118. 118
  119. 119
  120. 120
  121. 121
  122. 122
  123. 123
  124. 124
  125. 125
  126. 126
  127. 127
  128. 128
  129. 129
  130. 130
  131. 131